Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03453619 |
|---|---|
| Brief Title: | Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies |
| First Submitted : | February 27, 2018 |
| First Submitted that Met QC Criteria : | February 27, 2018 |
| First Posted : | March 5, 2018 |
| Last Update Submitted that Met QC Criteria : | February 6, 2020 |
| Last Update Posted : | February 7, 2020 |